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Zika virus (ZIKV) infection is typically characterized by a mild disease presenting with
fever, maculopapular rash, headache, fatigue, myalgia, and arthralgia. A recent animal
study found that ZIKV-infected pregnant Ifnar−/−mice developed vascular damage in
the placenta and reduced amount of fetal capillaries. Moreover, ZIKV infection causes
segmental thrombosis in the umbilical cord of pregnant rhesus macaques. Furthermore,
several case reports suggest that ZIKV infection cause coagulation disorders. These
results suggest that ZIKV could cause an alteration in the host hemostatic response,
however, the mechanism has not been investigated thus far. This paper aims to
determine whether ZIKV infection on HUVECs induces apoptosis and elevation of
tissue factor (TF) that leads to activation of secondary hemostasis. We infected
HUVECs with two ZIKV strains and performed virus titration, immunostaining, and flow
cytometry to confirm and quantify infection. We measured TF concentrations with flow
cytometry and performed thrombin generation test (TGT) as a functional assay to assess
secondary hemostasis. Furthermore, we determined the amount of cell death using
flow cytometry. We also performed enzyme-linked immunosorbent assay (ELISA) to
determine interleukin (IL)-6 and IL-8 production and conducted blocking experiments to
associate these cytokines with TF expression. Both ZIKV strains infected and replicated
to high titers in HUVECs. We found that infection induced elevation of TF expressions.
We also showed that increased TF expression led to shortened TGT time. Moreover,
the data revealed that infection induced apoptosis. In addition, there was a significant
increase of IL-6 and IL-8 production in infected cells. Here we provide in vitro evidence
that infection of HUVECs with ZIKV induces apoptosis and elevation of TF expression
that leads to activation of secondary hemostasis.
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INTRODUCTION
Zika virus (ZIKV) is a re-emerging arbovirus that belongs to
the genus Flavivirus of the family Flaviviridae. ZIKV was first
isolated from a rhesus macaque in 1947 in Uganda and has
not been recognized as an important viral pathogen until the
recent outbreaks in the Americas. Infection is asymptomatic in
the majority of cases (80%) and symptomatic patients develop
a febrile illness similar to many other infectious diseases (Baud
et al., 2017). Clinical symptoms are usually mild and last for
3–7 days without further complications. However, during the
recent outbreaks, severe symptoms and complications were
reported, including Guillain-Barré syndrome, (Parra et al., 2016)
severe birth defects, (Brasil et al., 2016b) fetal death (Sarmiento-
Ospina et al., 2016; Sharp et al., 2016; Zonneveld et al., 2016),
and coagulation disorders (Wu et al., 2017). The mechanism of
these complications, especially coagulation disorders, are still not
fully understood.
Under physiological conditions, hemostasis is orchestrated
by the coagulation and the fibrinolytic systems. Endothelial
cells (ECs) play an important role in regulating the activities
of pro-and anti-coagulation and fibrinolysis through expression
and production of several important mediators, including tissue
factor (TF), tissue factor pathway inhibitor (TFPI), tissue
plasminogen activator (tPA), plasminogen activator inhibitor
type-1 (PAI-1), and thrombomodulin (Levi et al., 2003). TF is
an important factor that initiates the activation of secondary
hemostasis. Several factors have been shown to activate and
down-regulate this protein (Levi and Poll, 2015; Bester and
Pretorius, 2016). For instance, interleukin (IL)-6 and 8 are pro-
inflammatory cytokines that regulate TF expression on several
cells such as human umbilical vein endothelial cells (HUVECs)
and monocytes (Wada et al., 1995; Neumann et al., 1997).
In addition, apoptotic cells could also activate the coagulation
system by increasing the surface TF expression (Greeno et al.,
1996). It has been shown that several viruses activate the
coagulation system especially through TF (Ruf, 2004). For
instance, treatment of Ebola virus (EBOV) infection with a
recombinant inhibitor of factor VIIa/TF was shown to result in
prolonged survival, which was associated with reduced activation
of coagulation and fibrinolysis (Geisbert et al., 2003). Dengue
virus (DENV), another flavivirus, has been shown to also cause
coagulation disorders and ECs have been shown to play a
central role in these pathological conditions (Wills et al., 2002;
Sosothikul et al., 2007; Basu and Chaturvedi, 2008).
Recently, it was found in a cohort study that 9% of infants from
ZIKV-infected pregnant woman were small for their gestational
age and the authors speculated that this condition occurred
as a consequence of fetal growth restriction or poor placental
perfusion (Brasil et al., 2016b). This study led to the hypothesis
that coagulation disorder of the umbilical cord could be one of the
explanations for abnormal fetal growth due to reduced perfusion
which has been shown for cytomegalovirus (CMV) infection
(Iwasenko et al., 2011; Lepais et al., 2014). CMV is known to have
vascular EC tropism, which causes cell damage and can lead to
thrombotic vasculopathy (Rahbar and Soderberg-Naucler, 2005).
Recent publications demonstrated that ZIKV also infects ECs
in vitro (Liu et al., 2016; Tabata et al., 2016; Richard et al., 2017).
HUVECs were shown to be more susceptible to ZIKV infection
compared to human ECs derived from aorta, coronary artery, and
saphenous vein (Liu et al., 2016). Interestingly, a recent report
revealed that ZIKV NS1 protein triggers endothelial barrier
dysfunction in vitro in a tissue-specific manner. The authors
found that ZIKV NS1 bind mainly on the surface of HUVECs
and brain ECs and cause increased vascular leakage in these
primary cells (Puerta-Guardo et al., 2019). In vivo evidence also
revealed that ZIKV-infected pregnant Ifnar−/−mice developed
vascular damage in the placenta and reduced amount of fetal
capillaries (Miner et al., 2016). Furthermore, pregnant rhesus
macaques infected with ZIKV developed segmental thrombosis
in the umbilical cord (Nguyen et al., 2017). Altogether, these data
suggest that hemostatic alterations occur during ZIKV infection.
However, there is limited evidence of hemostasis disorder
in ZIKV infection. Here, we provide in vitro evidence that
ZIKV infection of HUVECs induce apoptosis and increased TF
production which trigger the activation of secondary hemostasis.
MATERIALS AND METHODS
Cells
Human umbilical vein endothelial cells were harvested from
patients as previously described (Goeijenbier et al., 2015). Ethical
permission to use the leftover materials from mothers who gave
birth at Sophia Children Hospital was obtained from the Erasmus
MC medical ethics committee. Only cells up to passage four
and from one randomly selected donor were used in this study.
The identity of HUVECs was confirmed by flow cytometry using
Von Willebrand Factor (vWF) staining. HUVECs were grown
in human endothelial-SFM medium (Invitrogen, Life Sciences,
United States) containing 20% heat-inactivated fetal bovine
serum (HI-FBS, Lonza, Netherlands), 100 U penicillin (Gibco
Life Sciences, United States), 100 µg/ml streptomycin (Gibco
Life Sciences, United States), 20 ng/ml fibroblast growth factor
(Peprotech, United States) and 10 ng/ml endothelial growth
factor (Peprotech, United States). Vero cells (ATCC CCL-81,
United States) were grown in Dulbecco’s Modified Eagle Medium
(DMEM) containing 10% HI-FBS (Lonza, Netherlands), 100 U
penicillin, 100 µg/ml streptomycin, 2 mM L-glutamine, 1%
HEPES buffer, and 1% sodium bicarbonate (all from Gibco Life
Sciences, United States). All cells were grown at 37◦C and 5%
CO2. The cells were tested negative for mycoplasma by PCR.
Virus Strains
Two ZIKV strains were used in this study; ZIKV strain Uganda
976 (ZIKVAF) was kindly provided by Dr. Misa Korva (University
of Ljubljana) (European Virus Archive number 007-EVAg1585)
and Zika Suriname ZIKVNL00013 (ZIKVAS) was isolated from a
female patient in Netherlands who traveled to Suriname (Van Der
Eijk et al., 2016). Virus stocks used in this study were prepared on
Vero cells. ZIKV Uganda 976 with total passage number (P) 6
and ZIKVAS P4 were used in the experiments. Viral titers were
determined on Vero cells by calculating the 50% Tissue Culture
Infective Dose (TCID50) using the Spearman-Kärber formula
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(Kärber, 1931) after determining the presence of cytopathic
effects (CPE) after 5 days of incubation. As a control, infectious
virus was inactivated using beta-propiolactone (BPL) (Sigma-
Aldrich, United States, 1:4000 v/v) at 4◦C for 24 h. Subsequently,
BPL was inactivated by incubating for 1 h at 37◦C. All virus stocks
were stored at −80◦C until use. A summary of isolation history
of the ZIKV strains used in this study with related information is
provided in Table 1. A phylogenetic tree of the virus strains used
in this study was recently published (Anfasa et al., 2017).
Infection Experiments
Human umbilical vein endothelial cells were seeded into 96-
well- (2 × 104 cells per well) (Greiner, United States) or 24-
well- (2 × 105 cells per well) (Corning, United States) plates
depending on the experiment. After 24 h, confluent monolayers
were infected at a multiplicity of infection (MOI) of 0.1, 1, or
5, with infectious, BPL-inactivated virus or a mock (vero cell
culture medium) for 1 h at 37◦C in 5% CO2. Subsequently, the
supernatant was discarded and cells were washed three times with
RPMI 1640 medium (Gibco, Life Sciences, United States). New
medium with 10% HI-FBS was added and cells were cultured for
48 h. All of the experiments were performed according to the local
biosecurity safety procedures at the Department of Viroscience,
Erasmus Medical Center, which is a WHO collaborating center
for hemorrhagic fever viruses.
Determination of Virus Titer
Virus titers (TCID50) in the supernatant were determined by
log10 titration of the medium on Vero cells. Presence of CPE was
determined at 5 days post-infection (dpi) and the TCID50 was
calculated using the Spearman-Kärber method (Kärber, 1931).
Determination of Percentage of Infection
Cells were cultured on 96-well plates and infected with
MOI of 0.1 and 1. Infected cells were harvested, then
fixed and permeabilized with BD Cytofix/CytopermTM
solution (BD Biosciences, United States). To minimize
background, cells were incubated with 5% normal goat
serum (DAKO, Denmark) in BD Perm/Wash solution
(BD Biosciences, United States). ZIKV was detected using
mouse monoclonal antibody anti-flavivirus group antigen,
MAB10216, clone D1-4G2-4-15 (Millipore, Germany) 1:200
dilution and goat anti-mouse IgG conjugated with APC
(Life technologies, Netherlands) 1:250 dilution. Non-infected
cells and ZIKV-infected cells stained with mouse isotype
IgG2a antibody (DAKO, Denmark) were used as negative
and isotype controls. The percentage of infected cells was
measured using a BD FACS Canto II machine (BD Biosciences,
United States). Infected cells were defined as ZIKV Envelope +
cells (ENV+) while negative cells were defined as ZIKV ENV –
cells (ENV-).
Immunofluorescence Staining
Cells were grown on 96-well plates and infected with MOI
of 0.1 and 1. Cells were fixed with 4% paraformaldehyde
(PFA) and permeabilized with a mixture of 0.1% Triton
X-100 and ethanol 70% (1:1 dilution). Subsequently, cells
were incubated for 1 h with mouse monoclonal antibody
anti-flavivirus group antigen, MAB10216, clone D1-
4G2-4-15 (Millipore, Germany) 1:200 dilution at room
temperature. Next, cells were stained for 1 h with goat
anti-mouse IgG conjugated with APC (Life technologies,
Netherlands) 1:250 dilution at room temperature and
mounted in ProLong R© Diamond Antifade Mountant with
DAPI (Life technologies, United States). Non-infected cells
and ZIKV-infected cells stained with mouse isotype IgG2a
antibody (Dako, Denmark) were used as negative and
isotype controls. Representative images of infected cells
were generated on a Zeiss LSM 700 confocal laser scanning
microscope fitted on an Axio Observer Z1 inverted microscope
(Zeiss). All images acquired were processed using Zen 2010
software (Zeiss).
Determination of Apoptotic Cells
Cells were grown on 96-well plate and infected at an MOI
of 5. The number of apoptotic cells was measured using
the terminal deoxynucleotidyl transferase dUTP nick end
labeling (TUNEL) assay kit, in situ Cell Death Detection Kit,
Fluorescein (Sigma Aldrich, United States). The cells were
fixed with 4% PFA and permeabilized with triton X-100 1%
and ethanol 70% (1:1 v/v). Uninfected cells were treated with
90 IU/ml DNAse (Roche, Germany) for 15 min to serve
as a positive control (PC). TUNEL assay was performed
based on the manufacturer’s instructions. Non-infected cells
and ZIKV-infected cells stained only with labeling solution
were used as negative controls (NCs) as suggested by the
manufacturer. The number of TUNEL positive cells was
measured using a BD FACS Canto II machine (BD Biosciences,
United States). Data were analyzed using the FlowJo 10 software
(FlowJo, United States).
TABLE 1 | Source host, isolation and passage history of the ZIKV strains used in the study.
Lineage Strain Source
host
Year of
isolation
Location Passage history Genbank
Accession
number
EVAg number
Asian ZIKVNL00013 Human 2016 Suriname 4 × Vero KU937936 011V-01621
African Uganda 976 Monkey 1961 Uganda 2 × SMB, 3 × Vero
E6, 1 × Vero
NA 007V-EVAg1585
SMB, suckling mouse brain; Vero, African green monkey kidney cells; Vero E6, African green monkey kidney clone E6 cells; EVAg, European Virus Archive goes Global;
NA, Not available.
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Thrombin Generation Time Test
Cells were grown on 96-well plate and infected with MOI
of 0.1 and 5. Thrombin generation time (TGT) test was
performed as previously described (Goeijenbier et al., 2015).
Briefly, supernatant of cultured HUVECs on 96-well plate was
discarded. Cells were washed three times with RPMI 1640
medium (Lonza, Netherlands) and 80µL of pooled citrate plasma
from healthy donors was added to the monolayer together with
60 µL HEPES buffer [25 mM Hepes, 137 mM NaCl, 0.1%
Albumin]. As a standard, a serial dilution of recombinant TF
(Innovin, Germany) was performed in the absence of cells.
60 µL HEPES calcium [25 mM Hepes, 137 mM NaCl, 0.1%
Albumin,38 mM CaCl(2)] was then added and the plates were
measured directly at optical density (OD) 450 nm using a Tecan
Infinite 200 Pro ELISA reader (Tecan Group Ltd., Switzerland) in
a kinetic cycle measuring every 45 s for 1 h. TGT was defined as
the time at half the maximal OD. TF levels were also determined
from the ELISA values as previously described (Goeijenbier et al.,
2015). BPL-inactivated virus control was not used due to its
interference with the assay.
Quantification of Tissue Factor
Expression on HUVECs
Human umbilical vein endothelial cells were analyzed for
surface TF expression by flow cytometry. Briefly, HUVECs
were grown on 96-well plate and infected at an MOI of
5. Infected cells were harvested, then stained with rabbit
polyclonal anti-TF conjugated with Alexa Fluor 647 (Bioss
Inc., United States) at a 1:200 dilution or isotype control in
fluorescence activated cell sorter (FACS) buffer for 45 min
on ice and in the dark. Subsequently, the cells were fixed
and permeabilized with BD Cytofix/CytopermTM solution (BD
Biosciences, United States). Cells were incubated with 5%
normal goat serum (DAKO, Denmark) in BD Perm/Wash
solution (BD Biosciences, United States) for 10 min to minimize
background. ZIKV was detected using mouse monoclonal
antibody anti-flavivirus group antigen, MAB10216, clone D1-
4G2-4-15 (Millipore, Germany) at a 1:400 dilution for 45 min
on ice and in the dark. Subsequently, cells were incubated with
goat anti-mouse IgG conjugated with Alexa Fluor 488 (Life
technologies, Netherlands) at a 1:250 dilution for 45 min on
ice and in the dark. Non-infected cells and ZIKV-infected cells
stained with mouse isotype IgG2a antibody (DAKO, Denmark)
were used as negative and isotype controls. The percentage of
TF and infected cells were measured using a BD FACS Canto
II machine (BD Biosciences, United States). Data were analyzed
using the FlowJo 10 software (FlowJo, United States).
IL-6 and IL-8 ELISA
Cells were grown on 96-well plate and infected at an
MOI of 5. Supernatant of infected cells was collected
and followed by centrifugation for 10 min at 930 g. IL-
6 and IL-8 levels from the supernatant were measured
using IL-6 (Quantikine R&D, United States) and IL-8
(Quantikine R&D, United States) ELISA kits according to
the manufacturer’s instructions.
IL-6 and IL-8 Blocking Experiments
Cells were grown on 96-well plate and infected at an MOI
of 5. Following normal infection experiment as the above
protocol, anti-IL-6 (Quantikine R&D, United States) or IL-8
antibody (Quantikine R&D, United States) was added to the
wells according to our ELISA results and the manufacturer’s
recommendation. TF expression was subsequently determined
with flow cytometry at 24 and 48 hpi as the above protocol.
To confirm that the blocking experiments work, we incubated
HUVECs with IL-6 and IL-8 concentrations that we observed in
our study and determined the downstream activation pathway
of these cytokines. Briefly, HUVECs were grown on 96-well
plate and was cultured for 24 or 48 h. Dilution of anti-IL-6
or -IL-8 antibody was mixed with either IL-6 or IL-8 protein
(Quantikine R&D, United States) based on the concentrations
that we observed in our study for 30 min at 37◦C before it
was added to the cells. The cells were then cultured for 4 h.
Next, RNA was isolated from HUVECs with High Pure RNA
Isolation kit (Roche, Germany). Subsequently, cDNA synthesis
was performed with Superscript IV (Thermo Fisher Scientific,
United States). Expression of nuclear factor kappa B subunit
1 (NFKB1), tissue inhibitors of metalloproteinases-1 (TIMP1)
and hypoxia-inducible factor 1-alpha (HIF1A) genes were
determined with real-time PCR using the Taqman Universal PCR
Master mix II according to the manufacturer’s recommendation
(Applied Biosystems, United States). Gene expression was
corrected for the housekeeping gene glyceraldehyde 3-phospate
dehydrogenase (GAPDH) as described previously (Schmittgen
and Livak, 2008). All the primer-probe assays were obtained from
Applied Biosystems, United States.
Statistical Analysis
The statistical analyses were performed using GraphPad Prism
5.01 software for Windows. Student’s t-test or Mann Whitney
U test was used for the comparison of mean and median,
respectively, between two groups. For comparison between
multiple groups, one-way analysis of variance (ANOVA) test
with Tukey’s multiple comparison or Kruskal-Wallis test with
Dunn’s multiple comparison was used. P values ≤ 0.05 were
considered significant.
RESULTS
ZIKV Infects and Replicates in Primary
Human Umbilical Vein Endothelial Cells
To confirm that ZIKV infects and replicate in ECs, we determined
the replication kinetics of two strains of ZIKV, one of African
lineage and one of Asian lineage, using low MOIs (0.1 and 1).
In accordance with the previous study, (Liu et al., 2016) we found
that HUVECs supported infection for both ZIKVAF and ZIKVAS.
Both virus strains replicated to a titer of 107 TCID50/ml without
noteworthy differences in the replication kinetics (Figure 1A).
These results were supported by flow cytometry and IFA staining.
The flow cytometry data showed that at both MOI of 0.1 and 1 the
number of infected cells increased on average 5–10% (MOI 0.1)
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FIGURE 1 | Zika virus (ZIKV) infects and replicates efficiently in human umbilical vein endothelial cells (HUVECs). HUVECs were infected with two ZIKV strains at two
multiplicity of infections (MOIs; 1 and 0.1) and samples were collected at the designated times. (A) Infectious titers of supernatants collected at 0, 24, and 48 h
post-infection (hpi). Experiments were done in triplicate and data are representative of three independent experiments. Bars represent standard error of the mean
(SEM). (B) HUVECs were infected at two MOIs (0.1 and 1) and stained for the presence of ZIKV envelope by flow cytometry at 24 and 48 hpi. Experiments were
done in triplicate and data are representative of two independent experiments. The results are displayed as mean and bars represent SEM. (C) Representative flow
cytometry analyses plot to determine the percentage of infected cells at 48 hpi. (D) HUVECs were infected with two ZIKV strains and then imaged for the presence
of viral envelope protein at 24 and 48 hpi. 200× magnification.
and 27–35% (MOI 1) at 24 hpi to ±25% (MOI 0.1) and ±40%
(MOI 1) at 48 hpi (Figure 1B). The data shown in Figure 1C are
representative data of the flow cytometry analyses to determine
the percentage of infection. Flow cytometry results were also
confirmed by IFA intracellular staining of ZIKV infected cells at
low MOIs (Figure 1D). Taken together, these data confirm that
ZIKV could infect and replicate efficiently in HUVECs.
Increased TF Concentrations and
Shortened Thrombin Generation Time
After ZIKV Infection of HUVECs
To test whether ZIKV infection induces activation of secondary
hemostasis, we incubated HUVECs with both ZIKV strains at a
low MOI (0.1) and high MOI (5) or virus-free cultured medium
from Vero cells. Two ZIKV lineages were used to assess whether
activation of secondary hemostasis is lineage-specific or not.
We measured TGT as a functional assay to assess secondary
hemostasis. Thrombin generation was quantified directly on
infected cells by incubating plasma on cells and initiating
coagulation by the addition of calcium ions (Figures 2A,B). We
observed that ZIKV-infected HUVECs triggered plasma clotting
faster compared than mock control (Figure 2B). The significant
increase was mainly seen at 48 hpi for both strains (p < 0.0001
MOI 5 ZIKVAF, p = 0.0007 MOI 1 ZIKVAF; p = 0.0002
ZIKVAS). We further quantified the mean TF concentrations
after ZIKV infection, calculated from TGT standard curve as
described previously (Figures 2C,D) (Goeijenbier et al., 2015).
TF concentrations were significantly increased for ZIKVAF at
both MOIs at 48 hpi (p = 0.0007 MOI 0.01; p< 0.0001 MOI 5) and
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FIGURE 2 | Zika virus infection of HUVECs leads to increased tissue factor (TF) expression and activation of secondary hemostasis. HUVECs were infected with an
MOI of 0.1 or 5 with both ZIKV strains and thrombin generation time (TGT) test was performed as a functional assay to assess secondary hemostasis at 24 and 48 h
post-infection (A,B). TGT was significantly shortened for ECs infected with ZIKVAF (MOI 0.1 and 5) and ZIKVAS (MOI 5) at 48 hpi (B). (C,D) TF concentration was
calculated from a standard curve to determine whether there is an increase of TF expression at 24 and 48 hpi based on previous study (Goeijenbier et al., 2015)
(Continued)
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FIGURE 2 | Continued
TF expression increased significantly at 48 hpi for both strains (ZIKVAF: MOI 0.1 and 5; ZIKVAS: MOI 5). Experiments were done in eight replicates and data are
representative of three independent experiments. (E,F) TF expression was also confirmed with flow cytometry. Increased TF expression was observed for both virus
strains against BPL and negative control (NC) at 24 and 48 hpi. Approximately 61 % of cells expressed TF at 48 hpi for ZIKVAF. (G,H) Double staining experiments
were performed to determine whether increased TF expression occurred in infected or bystander cells. Black bars represent the total amount of TF+ cells while gray
bars represent the percentage of double positive cells for both ZIKV and TF. Less than 40% of total TF+ cells were double positive for both ZIKV and TF at 24 hpi
(G). Meanwhile, <25% of total TF+ cells were double positive for both ZIKV and TF at 48 hpi (H). Experiments were done in triplicate and data are representative of
two independent experiments. All the results are displayed as mean and bars represent SEM. Statistical analyses were performed against mock. Statistical
significance is shown: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
only at MOI 5 for ZIKVAS (p = 0.0002) (Figure 2D). Since we only
observed significant differences mainly with MOI of 5 and based
on the in vitro studies of DENV (Dewi et al., 2004) and puumala
virus (Goeijenbier et al., 2015), which showed that a high MOI
is needed to observed permeability and/or hemostatic disorders
in vitro (HUVECs models), we decided to continue with this
MOI for the rest of the experiments. We noticed that increased
TF expression were detected since 24 hpi (Figure 2E) and was
higher at 48 hpi (Figure 2F). Both ZIKV strains significantly
increased TF concentrations compared to BPL at 24 hpi (ZIKVAF:
p = 0.0022; ZIKVAS: p = 0.002) and 48 (ZIKVAF: p = 0.002;
ZIKVAS: p = 0.0004).
To determine whether increase TF levels occurred in
infected or bystander cells, we performed double staining
assays against TF and ZIKV envelope (Figures 2G,H). We
measured TF on both ENV+ and ENV- cells, but increased
TF mainly occurred in the bystander (ENV-) evidenced
by the fact that <26% of all the positive TF cells were
double positive cells at 48 hpi (ZIKVAF: 25.5%; ZIKVAS:
7.5%) (Figure 2H). Collectively, our data indicate that ZIKV
infection on HUVECs induces increased TF concentration
mostly through bystander effect that allows activation of
secondary hemostasis.
ZIKV Infection of HUVECs Induces
Apoptosis Mainly Through Infection
Previous studies indicated that cell apoptosis could activate the
coagulation system (Greeno et al., 1996; Yang et al., 2017).
In addition, several studies showed that ZIKV infection of
several primary cells induced cell death (Quicke et al., 2016;
Anfasa et al., 2017). To determine whether ZIKV infection
induced cell death of HUVECs, we assessed cell viability using
a TUNEL assay. We found that infection with both strains led
to significant morphological changes and increased cell death
at 48 hpi (Figure 3A). No significant differences in cell death
were observed at 24 hpi between the groups (Figure 3B). Cells
treated with DNAse showed approximately 90% of TUNEL+
cells at both 24 and 48 hpi. ZIKVAF induced significantly
more cell death (p = 0.005) than ZIKVAS at 48 hpi (65% vs.
55%) (Figure 3C). To determine whether cell death occurred
in infected or bystander cells, we performed double staining
experiments against ZIKV envelope and TUNEL positive cells.
We found that cell death mainly occurred due to infection,
especially with ZIKVAF (Figures 3D,E). Approximately 60% of
the total death cells were also positive for ZIKVAF while the
number was 40% for ZIKVAS. Collectively, our data indicate that
ZIKV infection of HUVECs leads to increased cell death mainly
in the infected cells.
ZIKV Infection on HUVECs Triggers
Production of
Pro-inflammatory Cytokines
Previous studies suggested that IL-6 and IL-8 can also increase
TF expression on HUVECs and monocytes (Wada et al., 1995;
Neumann et al., 1997). To assess whether ZIKV infection led to
increased production of IL-6 and IL-8, the culture supernatant of
infected HUVECs was collected at 0, 24, and 48 hpi. We found
that IL-6 and IL-8 concentrations were significantly increased
in the supernatant of ZIKV infected-cells compared to the
controls. ZIKVAF induced a higher production of IL-6 and IL-
8 than ZIKVAS, BPL-inactivated virus and mock control at
48 hpi (Figure 4A). IL-6 and IL-8 levels increased significantly
compared to BPL-inactivated virus (IL-6: p = 0.0018; IL-8:
p < 0.0001) and NC (IL-6: p = 0.0001; IL-8: p < 0.0001) 2 days
after infection. ZIKVAS induced increased levels of IL-6 at 24
(p < 0.0001) and 48 (p < 0.0001) hpi compared to mock control
(Figures 4A,B). Interestingly, ZIKVAS BPL control also induced
elevated levels of IL-6 production.
To determine whether increase IL-6 and IL-8 production
was linked to increased TF productions, we further performed
blocking experiments against both cytokines and measured
TF levels at 24 and 48 hpi. We first investigated whether
the concentrations of anti-IL-6 and -IL-8 that we used could
neutralize IL-6 and IL-8 by determining the expression levels
of several genes of the downstream activation pathway of
both cytokines. We found that the gene expression levels of
NFKB1 and TIMP1 were significantly reduced in IL-6 with
anti-IL-6 treatment (AB), comparable to (NC; medium only),
compared to cells with IL-6 only (PC) at both 24 and 48 hpi
(Figure 4C). Similarly, NFKB1 and HIF1A expression levels were
reduced in the presence of anti-IL-8 (Figure 4D). These results
suggest that both monoclonal antibodies could neutralize the
respective cytokines. Next, blocking experiments were conducted
and TF expression was measured. The results revealed modest
reduction of TF (Figures 4E,F), which suggest that IL-6 and
IL-8 did not contribute significantly to the increased TF
expression on HUVECs.
DISCUSSION
The present study addresses the effect of ZIKV infection of
ECs in vitro on TF expression and apoptosis. We observed that
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FIGURE 3 | Zika virus infection on HUVECs induces cell death mainly through infection. HUVECs were infected with a MOI of 5 with both ZIKV strains.
(A) Cytopathic effect (CPE) was observed at 48 h post-infection (hpi) for both ZIKV strains with light microscopy at 200× magnification. More CPE was observed
with ZIKVAF. (B,C) To measure cell death, cells were stained for DNA fragmentation with the terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)
assay kit at 24 and 48 h post-infection (hpi). Both ZIKV strains induced cell death at 48 hpi. ZIKVAF induced more cell death compared to ZIKVAS (p < 0.01).
Experiments were done in triplicate and data are representative of two independent experiments. (D) To determine whether cell death was caused by direct infection
or bystander effect, we performed double staining directed against ZIKV envelope protein and TUNEL with flow cytometry. HUVECs were infected at an MOI of 5 and
samples were collected at 48 hpi. Majority of the TUNEL+ cells were also positive for ZIKV ENV. (E) Representative flow cytometry analyses plot to determine the
ZIKV ENV+ and TUNEL+ cells at 48 hpi. Experiments were done in triplicate and data are representative of two independent experiments. All the results are
displayed as mean and bars represent SEM. Statistical significance is shown: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
infection with both an African and an Asian strain of ZIKV
resulted in increased TF expression on HUVECs, which led
to a shortened TGT. We showed that increased TF expression
were mainly induced in ENV-positive cells, which indicate an
indirect effect of infection on TF expression. It is important to
note that very early stage of infection may lead to increased TF
expression where the levels of ENV expression is still under the
limit of detection.
Tissue factor is a major activator of the coagulation
cascade during virus infections (Antoniak and Mackman, 2014).
A previous study with EBOV indicated that the over-expression
of TF in primate monocytes/macrophages plays an important
role in triggering the pro-coagulant state and consequently
hemorrhagic complications (Geisbert et al., 2003). The role of TF
in hemorrhagic fevers has also been described in dengue in that
infection of ECs with DENV resulted in increased TF expression
via the phosphorylation of p38 and ERK1/2 MAPKs (Huerta-
Zepeda et al., 2008). Excess TF production during infection
could thus lead to increased clotting and eventually consumptive
coagulopathy or even disseminated intravascular coagulation
(DIC). Our results support the recent observations in humans
and animal models, which suggest that hemostasis alterations
occur during ZIKV infection (Brasil et al., 2016a,b; Chraibi
et al., 2016; Karimi et al., 2016; Miner et al., 2016; Sarmiento-
Ospina et al., 2016; Sharp et al., 2016; Zonneveld et al., 2016;
Nguyen et al., 2017; Wu et al., 2017).
Liu et al. (2016) showed recently that ZIKV could infect ECs
from different vascular beds. Interestingly, the authors found that
HUVECs were the most susceptible to ZIKV infection compared
to human ECs derived from aortic and coronary artery, as well
as the saphenous vein. Moreover, a recent study found that
ZIKV NS1 specifically induced vascular leakage in HUVECs and
brain ECs from several primary ECs that were tested (Puerta-
Guardo et al., 2019). EC heterogeneity has been described
between different organs, both on molecular, and functional
levels (Aird, 2012). Therefore, infection of ECs from different
vascular beds with certain pathogens may lead to different
pathogenic outcomes. This hypothesis has been supported for
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FIGURE 4 | Zika virus-infected HUVECs produce pro-inflammatory cytokines. HUVECs were infected with a MOI of 5 with both ZIKV strains and supernatants were
collected at the designated times. Significantly, increased levels of IL-6 (A) and IL-8 (B) were detected at 48 h post-infection (hpi) for ZIKVAF. (C,D) To investigate
whether the concentrations of anti-IL-6 and -IL-8 that we used were sufficient to neutralize IL-6 and IL-8 concentrations at 24 and 48 hpi, we determined the gene
expression levels of NFKB1, TIMP-1, and HIF1A, which are the downstream activation pathways of IL-6 (NFKB1 and TIMP1) and IL-8 (NFKB1 and HIF1A). The gene
expression levels of NFKB1 and TIMP1 were significantly lower in IL-6 with anti-IL-6 treatment (AB) compared to positive controls (PC; IL-6 protein only) and similar
to negative controls (NCs) (C). The gene expression levels of NFKB1 and HIF1A were significantly reduced in IL-8 with anti-IL-8 treatment (A,B) compared to PC
(IL-8 protein only) and equal to NC (D). (E,F) Modest TF expression reduction was observed after IL-6 and IL-8 blocking experiments at 24 and 48 hpi. The results
are based on three (Panels (A,B) and two (Panels C–F) independent experiments. All experiments were performed in triplicate except for Panels (C,D) that was
performed in duplicate. The results are displayed as mean and bars represent SEM. Statistical significance is shown: ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001.
other hemorrhagic viruses such as DENV and puumala virus
(Peyrefitte et al., 2006; Goeijenbier et al., 2015). In contrast to
our results, in vitro studies using human brain microvascular
endothelial cells (hBMECs) and human retinal microvascular
ECs observed limited or no cytopathology during ZIKV infection
(Mladinich et al., 2017; Roach and Alcendor, 2017). Moreover,
Mladinich et al. (2017) found that ZIKV infected and persisted
in hBMECs. Whether vascular heterogeneity play a role in the
pathogenesis of ZIKV-induced brain disorders and hemostasis
alterations warrants further study.
It is known that pro-inflammatory cytokines play an
important role in activation and downregulation of the
coagulation system. We found that ZIKV infection of HUVECs
leads to increased levels of IL-6 and IL-8 production. Our data
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is in line with a study that showed increased IL-6 production
of ZIKV-infected retinal ECs (Roach and Alcendor, 2017). We
observed elevated levels of IL-6 also in HUVEC incubated
with BPL-inactivated ZIKVAS suggesting that binding of viral
proteins to EC alone may stimulate production of IL-6. This
is in line with the study of Roach and Alcendor (2017) that
used a heat-inactivated Asian strain (PRVABC59) of ZIKV and
reported increased levels of IL-6 production compared to mock
control. We further blocked IL-6 and IL-8 during infection to
determine whether these cytokines contributed to increased TF
expression using concentrations that were showed to neutralized
these cytokines (Takeuchi et al., 2015). Our results indicated a
modest TF expression reduction when both IL-6 or IL-8 were
blocked, indicating limited effect of these cytokines neutralization
on TF expression.
Several reports revealed that ZIKV infection of primary cells
induced apoptosis (Tang et al., 2016; Anfasa et al., 2017). In
the present study, we observed that both ZIKV strains induced
significant cell death. It is noteworthy that approximately 20%
of dead cells were found in the mock control after 48 h of
culture, which might be explained by the donor since we observed
differences among various donors (data not showed). It has
been shown that apoptotic cells are procoagulant (Bombeli
et al., 1997; Bouvy et al., 2014; Yang et al., 2017). Although
the mechanism of how apoptotic cells activate coagulation
system remains to be determined, it was shown that both
adherent and detached apoptotic HUVECs become procoagulant
by increased expression of phosphatidylserine (PS) and the loss
of anticoagulant components such as TM and TFPI (Bombeli
et al., 1997). Another possibility is that apoptotic ECs produce
extracellular vesicles contributing to a procoagulant phenotype
of the cells (Bouvy et al., 2014).
Our study has several limitations. First, we did not
determine the whole spectrum of the hemostasis pathway.
Second, we did not address the other factors that could
trigger TF expression on HUVECs. Therefore, further
studies to understand the mechanism of hemostasis
activation during ZIKV infection is needed. However,
our study provides evidence of increased TF expression,
mostly due to bystander effect, that leads to activation of
secondary hemostasis.
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